![]() |
|
![]() |
||
|
Treatment has to start somewhere |
||||
|
The point of view you recently ran in your magazine ('Mum-to-baby
prevention programmes questioned', PN
78) is doing serious damage to our efforts to ensure access to medicines.
The decision to use nevirapine, as opposed to another regime, for the
prevention of mother-to-child transmission (MTCT) was the decision of
the South African government, not the TAC. Eventually, long-course antiretrovirals
might become a reality in the South African public sector, but not yet.
Nevirapine is used in the US as part of combination therapy for MTCT.
It is disturbing that Positive Nation, ostensibly a magazine representing
the cause of people with HIV, is taking a line on this issue which is
detrimental to the efforts of people with HIV in one of the worst-hit
countries in the world. |
||||
|
page 1 of 4 contents
of issue 79 |
||||
| Write
to: Letters, Positive Nation, 250 Kennington Lane, London SE11 5RD or send an email to the editor or fax 020 7564 2128. Please include your address and phone number although these will not be published. Letters may be edited for length. |
||||
| Hope Mhereza Byarugaba, Manager, Hillingdon Aids Response Trust | ||||